All content at a glance
Beiträge nach Kategorie
- Kategorie: Company News
- LTS and Revive Therapeutics enter into Feasibility Agreement to develop Oral Psilocybin Thin Film Strip
- LTS receives notice of allowance for U.S. patent related to Asenapine patch
- LTS signs research collaboration agreement for Micro Array Patches
- LTS presents Microarray Patches at the Developments and Innovations in the Drug Delivery Market
- New web seminar Microarray patch systems
- LTS receives the “Highest Reputation” award
- New LTS Web seminar
- LTS provides new insights
- LTS announces the appointment of David Doles as new President and Chief Executive Officer for its US affiliate LTS Corp.
- European patent granted for LTS’ asenapine TTS
- Dr. Reddy’s re-launches generic of Buprenorphine and Naloxone Sublingual Film
- Chairman of the LTS AG supervisory board changes
- Intec Pharma Partners with LTS for Manufacture of Accordion Pill Carbidopa/Levodopa for Treatment of Parkinson’s Disease
- E Ink and LTS Partner Develop Smart Patch to Improve Medical Management
- The LTS Asia Office with a new address
- LTS affiliate IIS receives 1st European permit to manufacture microarray patches
- End-to-end monitoring assures drug safety: LTS progresses in drug serialization
- New member of the Executive Board appointed
- LTS attends DCAT WEEK 2017 in NEW YORK
- LTS exhibts at the AAPS in Denver, CO
- LTS supports Unified Cup
- LTS exhibits at the CPHI/ICSE in Barcelona, Spain
- New Chief TechOps Officer appointed
- LTS – patient oriented!
- LTS attends DCAT 2016 in NEW YORK
- Teva launches ZECUITY® migraine patch
- LTS becomes Business Team Partner of German Bundesliga soccer team TSG 1899 Hoffenheim
- LTS opens Asia representative office in Shanghai
- Hopp acquires LTS shares from Novartis & BWK
- LTS implements serialization
- Micro-needles and Hightech-jets
- LTS sets up a central new logistics center at its headquarters in Andernach
- New Executive Management at LTS AG
- Kategorie: Fairs
- Kategorie: Press Releases
- EsoCap and LTS announce major milestone archievement in their cooperation
- LTS marketing campaign, a complete success – awarded!
- LTS and LIVZON enter into license and collaboration agreement to develop and commercialize ASENAPINE TTS
- LTS appoints Bas van Buijtenen as new Chief Executive Officer
- Completion of solar panel installation at LTS Corp.
- German health authorities grant LTS the manufacturer’s authorisation for capsules
- The LTS company kindergarten celebrates its 10th birthday
- LTS donates fire-truck to Zichow fire brigade!
- Changes in the Supervisory Board of the LTS AG
- LEO Pharma A/S and LTS Lohmann Therapie-Systeme AG initiate first-ever clinical trial of microarray patches for psoriasis treatment
- EsoCap announces kick-off of an industrial development collaboration with LTS
- LTS AG donates a new pediatric anaesthesia trolley to the St. Nikolaus-Stifts Hospital in Andernach.
- LTS Lohmann Therapie Systeme AG to present at the J.P. Morgan 35th Annual Healthcare Conference 2017
- CEO of LTS Lohmann Therapie-Systeme AG, Prof. Dr Wolfgang Hartwig, retires
- LTS supports WHO and African countries in their efforts to eliminate river blindness
- Most Innovative European New Product of the Year 2014 – NiQuitin® Strips
- Innovation prize 2013 – Alacare®
- LTS Lohmann innovatively connected with Korea